all report title image
  • Published On : Oct 2020
  • Code : CMI4221
  • Industry : Medical Devices
  • Pages : 176
  • Formats :

A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to quantify expression levels of numbers of genes simultaneously or to genotype multiple regions of a genome. The approach finds application in drug R&D, clinical diagnosis, agriculture, environment control, and other sectors.

Statistics:

The global array market (life science and biotechnology instruments) is estimated to account for US$ 4,899.9 Mn in terms of value in 2020 and is expected to reach US$ 12,892.5 Mn by the end of 2027.

Global Array Market (Life Science and Biotechnology Instruments): Drivers

High prevalence of cancer is expected to propel growth of the global array market (life science and biotechnology instruments) over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Moreover, increasing adoption of genetic testing is also expected to propel growth of the global array market (life science and biotechnology instruments) over the forecast period. For instance, in April 2020, Axovant Gene Therapies collaborated with Invitae Corporation, a provider of advanced medical genetics, to offer free genetic testing in the U.S. and Canada for pediatric lysosomal storage disease.

Statistics:

DNA Array held dominant position in the global array market (life science and biotechnology instruments) in 2019, accounting for 50.3% share in terms of value, followed by Protein array and tissue array, respectively.

Figure 1. Global Array Market Share (%), by Value, by Type, 2019

Array  | Coherent Market Insights

Global Array Market (Life Science and Biotechnology Instruments): Restraints

Lack of technically trained resources, especially in emerging economies, is expected to hinder growth of the global array market (life science and biotechnology instruments). Technologically versed and skilled resources are a prerequisite for using DNA/gene microarrays and sequencers. Shortage of such trained personnel is expected to limit market growth.

Moreover, availability of alternative methods such as high throughput screening, genomics, bio-analytical instruments, pharmacogenomics, bioinformatics, proteomics, RNAi, nanotechnology, combinatorial chemistry is also expected to limit growth of the global array market (life science and biotechnology instruments).

CMI table icon

Array Market (Life Science and Biotechnology Instruments) Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 4,899.9 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 14.8% 2027 Value Projection: US$ 12,892.5 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Type: DNA Array, Protein Array, Tissue Array, Cell Array.
  • By End User: Biopharmaceutical and Pharmaceutical, Diagnostic Laboratories, Research Laboratories, Others.
Companies covered:

Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation

Growth Drivers:
  • Technological advancement
  • Increasing genetic testing
Restraints & Challenges:
  • High costs
  • Limited awareness

Global Array Market (Life Science and Biotechnology Instruments): Opportunities 

R&D in cancer is expected to offer lucrative growth opportunities for players in the global array market (life science and biotechnology instruments). For instance, in April 2020, researchers from National Defense Medical Center, Taiwan, reported use of DNA microarray gene expression profiles in a research to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages.

Moreover, significant development in personalized medicines is also expected to fuel growth of the global global array market (life science and biotechnology instruments) over the forecast period. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.

Statistics:

The global array market (life science and biotechnology instruments) was valued at US$ 4,276.1 Mn in 2019 and is forecast to reach a value of US$ 12,892.5 Mn by 2027 at a CAGR of 14.8% between 2020 and 2027.

Figure 2. Global Array Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Array  | Coherent Market Insights

Market Trends/Key Takeaways

Major players in the global array market (life science and biotechnology instruments) are focused on adopting M&A strategies to enhance their market share. For instance, in December 2019, Oncology Pharma, Inc. signed a Letter of Intent to acquire at least a 50% stake in Diagnomics, Inc., a private CLIA certified & CAP accredited private molecular Genomics lab and provider of DNA microarrays, Next Generation Sequencing, and real-time PCR solutions

R&D in arrays is expected to propel growth of the global array market (life science and biotechnology instruments) over the forecast period. For instance, in April 2020, researchers from National Defense Medical Center, Taiwan, reported use of DNA microarray gene expression profiles in a research to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages.

Global Array Market (Life Science and Biotechnology Instruments): Competitive Landscape

Major players operating in the global array market (life science and biotechnology instruments) include, Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc.,  PathogenDx, Inc., and Twist Bioscience Corporation.

Global Array Market (Life Science and Biotechnology Instruments): Key Developments

Major players in the global array market (life science and biotechnology instruments) are focused on launching new products to expand their product portfolio. For instance, in December 2019, PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology

Similarly, in February 2018, Thermo Fisher Scientific launched the Applied Biosystems Axiom Microbiome Array for simultaneous detection of archaea, bacteria, fungi, protozoa and viruses in human and non-human samples.

A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to quantify expression levels of numbers of genes simultaneously or to genotype multiple regions of a genome. The approach finds application in drug R&D, clinical diagnosis, agriculture, environment control, and other sectors.

Restraints of the Global Array Market

Major factors hampering the growth of the array market during the forecast period constitutes of high costs, and limited awareness.

Key features of the study:

  • This report provides in-depth analysis of the global array market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global array market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global array market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Array Market, By Type:
    • DNA Array
    • Protein Array
    • Tissue Array
    • Cell Array
  • Global Array Market, By End User:
    • Biopharmaceutical and Pharmaceutical
    • Diagnostic Laboratories
    • Research Laboratories
    • Others
  • Global Array Market, By Geography:
    • North America
      • By Type
        • DNA Array
        • Protein Array
        • Tissue Array
        • Cell Array
      • By End User
        • Biopharmaceutical and Pharmaceutical
        • Diagnostic Laboratories
        • Research Laboratories
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Type
        • DNA Array
        • Protein Array
        • Tissue Array
        • Cell Array
      • By End User
        • Biopharmaceutical and Pharmaceutical
        • Diagnostic Laboratories
        • Research Laboratories
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • DNA Array
        • Protein Array
        • Tissue Array
        • Cell Array
      • By End User
        • Biopharmaceutical and Pharmaceutical
        • Diagnostic Laboratories
        • Research Laboratories
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Type
        • DNA Array
        • Protein Array
        • Tissue Array
        • Cell Array
      • By End User
        • Biopharmaceutical and Pharmaceutical
        • Diagnostic Laboratories
        • Research Laboratories
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Type
        • DNA Array
        • Protein Array
        • Tissue Array
        • Cell Array
      • By End User
        • Biopharmaceutical and Pharmaceutical
        • Diagnostic Laboratories
        • Research Laboratories
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • DNA Array
        • Protein Array
        • Tissue Array
        • Cell Array
      • By End User
        • Biopharmaceutical and Pharmaceutical
        • Diagnostic Laboratories
        • Research Laboratories
        • Others
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Naffymetrix Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Illumina Inc.
    • Roche Diagnostics Inc.
    • Bio-Rad Laboratories
    • Life Technologies
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • Siemens Healthineers
    • Agilent Technologies Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global array market (life science and biotechnology instruments) was valued at US$ 4,276.1 Mn in 2019 and is forecast to reach a value of US$ 12,892.5 Mn by 2027 at a CAGR of 14.8% between 2020 and 2027.
Major factor driving the growth of global array market during the forecast period include technological advancement, and increasing genetic testing.
Major factors hampering the growth of the array market during the forecast period constitutes of high costs, and limited awareness.
DNA array held dominant position in the global array market in 2019.
North America Array market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo